Rankings
▼
Calendar
HOTH Q3 2020 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOTH
Hoth Therapeutics, Inc.
$15M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-3.94
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$2M
Stock-Based Comp.
$693,147
Balance Sheet
Total Assets
$6M
Total Liabilities
$572,871
Stockholders' Equity
$5M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$8,354
+100.0%
Operating Income
-$2M
-$2M
-27.4%
Net Income
-$2M
-$2M
-24.8%
← FY 2020
All Quarters
Q4 2020 →